StockWatch
·

JK TYRE & INDUSTRIES LTD.

BSE: 530007

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
3.9K
+0.6%+35.8%
Expenditure
3.8K
+7.0%+44.1%
Net Profit
72.54
-64.4%-57.3%
OPM %
7.36%
-4.49pp-4.38pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.001.1K2.2K3.3K4.4KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Volume Surge Masks Earnings Collapse

margin compression · raw material lag · volume growth

Result verdictFollow-upQ1 FY2714 Aug 20266 minAutomobile

Volume growth masks margin collapse and execution risk

volume resilience · margin compression · price lag

TranscriptDeep diveQ1 FY2714 Aug 20266 minAutomobile

JK Tyre Q1FY27: consolidated PAT down 73% YoY to ₹44 Cr on RM cost, Mexico hit margins

tyre industry · margin compression · raw material costs

ResultsQ1 FY2707 Aug 20263 minAutomobile
Latest
Board Meeting7 Aug, 1:34 pm

JK Tyre Q1FY27: consolidated PAT down 73% YoY to ₹44 Cr on RM cost, Mexico hit margins

JK Tyre's consolidated Q1 FY27 revenue rose a modest 2.0% YoY to ₹3,946 Cr (down 6.6% QoQ from the seasonally strong Q4), but profitability collapsed: PBT fell to ₹53.76 Cr from ₹208.07 Cr a year ago, and net profit for the period (including share of associates) dropped 73.0% YoY to ₹44.09 Cr, and 75.2% QoQ, with EPS at ₹1.55 versus ₹5.74 (YoY) and ₹6.25 (QoQ). The decline is not a one-off-driven optical effect — both the current and year-ago quarters carried net exceptional gains (₹10.85 Cr and ₹12.58 Cr respectively), so pre-exceptional PBT is the cleaner comparison, and it still fell 78.1% YoY (₹42.91 Cr vs ₹195.49 Cr); adjusted PAT is estimated down roughly 78% YoY once exceptionals are stripped from both periods, worse than the 73% headline decline. Standalone (India-only) PAT of ₹72.54 Cr fell a comparatively smaller 52.9% YoY, underscoring that the Mexico operation (JK Tornel) is the disproportionate drag on the group number — its segment result before finance costs and tax swung to a –₹45.83 Cr loss from –₹4.70 Cr a year earlier, which the filing attributes to geopolitical disruption to input availability and IR issues during wage negotiations that management says have since been resolved. The margin bridge is the core story: consolidated EBITDA (PBIDT) margin compressed to 6.8% (₹267.64 Cr) from roughly 10.7% a year ago and 11.6% last quarter. Cost of Materials Consumed jumped to 76.9% of revenue (₹3,036.5 Cr, +34% YoY) from 58.6% a year ago, consistent with management's prior guidance of an 18-20% raw-material cost spike in Q1FY27 flowing from West Asia-linked crude and petro-input inflation — roughly 70% of tyre industry inputs are petroleum-derived, per the company's own press release. Management had guided that staggered price hikes (4-7% initially, 5-6% more planned) would offset this; the hikes appear to have been taken but margin protection fell well short of what the guidance implied, so this quarter reads as a miss against management's own Q4FY26 outlook on the profitability side, even as the guided cost pressure itself materialised almost exactly as flagged. We found no specific street/consensus preview for this quarter to benchmark against, so vs-Street is not assessable from available sources. The CMD's press release framing ("steady performance", "resilient topline") is only half the picture: domestic volumes reportedly grew 25% YoY (replacement +12%, OE +42%), which is real underlying demand strength, but this volume growth did not translate to profit given the RM cost shock and Mexico losses — the numbers diverge from the press release's upbeat tone on the bottom line even as they support it on volumes. Exceptional items this quarter (net ₹10.85 Cr consolidated gain) comprise a ₹17.91 Cr forex gain, a ₹4.31 Cr VRS cost and a ₹2.75 Cr stamp duty charge tied to the Cavendish Industries Ltd (CIL) amalgamation completed in December 2025; other quarter developments — a 'Best in Class' ESG rating for the third straight year, a ₹2 Cr tax-interest waiver from Jaipur authorities, and the July 30 dividend record date — are immaterial to the P&L story. Going into Q2 FY27, the key markers are whether the additional 5-6% price hike restores EBITDA margin toward the 10-12% band the company was running at before this quarter, and whether the Mexico segment recovers now that the cited IR issues are resolved. Management reiterated confidence in double-digit FY27 revenue growth and improved profitability through cost reduction and premiumization, alongside the previously approved ₹4,980 Cr TBR/PCR brownfield capex programme — both are unverified forward claims from management, not confirmed by this quarter's numbers.

7 Aug 2026, 01:34 pm

Corporate Events

Board MeetingJKTYRE
2026
6Aug

Board Meeting

To receive, consider and adopt the audited standalone and co…

BSE Filing ↗
Board MeetingJKTYRE
2026
26May

Board Meeting

The board meeting is scheduled to consider and approve the s…

BSE Filing ↗
Board MeetingJKTYRE
2026
6Feb

Board Meeting

Consider and approve The Standalone and Consolidated extext…

BSE Filing ↗
Board MeetingJKTYRE
2025
27Oct

Board Meeting

Consider and approve the standalone and consolidated Unaudit…

BSE Filing ↗
Board MeetingJKTYRE
2025
8Aug

Board Meeting

Consider and approve the Standalone and Consolidated Unaudit…

BSE Filing ↗
Board MeetingJKTYRE
2025
7Aug

Board Meeting

Transact the following business: a) the audited standalone f…

BSE Filing ↗
DividendJKTYRE
2025
31Jul

₹2 / share

BSE Filing ↗
Board MeetingJKTYRE
2025
20May

Board Meeting

Consider and approve the (Standalone and Consolidated) finan…

BSE Filing ↗
Board MeetingJKTYRE
2025
4Feb

Board Meeting

consider and approve the standalone and consolidated Unaudit…

BSE Filing ↗
Board MeetingJKTYRE
2024
5Nov

Board Meeting

Considering And Approving The Standalone And Consolidated Un…

BSE Filing ↗
Board MeetingJKTYRE
2024
21May

Board Meeting

Consideration and approval of (Standalone and Consolidated) …

BSE Filing ↗
DividendJKTYRE
2024
16Feb

₹0.01 / share

BSE Filing ↗
Board MeetingJKTYRE
2024
6Feb

Board Meeting

Consideration and approval of standalone and consolidated Un…

BSE Filing ↗
Board MeetingJKTYRE
2023
22Dec

Board Meeting

Consider and approve issue price of equity shares

BSE Filing ↗
Board MeetingJKTYRE
2023
1Nov

Board Meeting

Board meeting to consider and approve fund raising options f…

BSE Filing ↗